Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
- DOI
- 10.2147/ott.s131756
- Published
- 2017-09
- Container
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/ott.s131756,
title = {Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report},
author = {Dragana Jovanovic and Ruza Stevic and Marta Velinovic and Milica Kontic and Dragana Maric and Jelena Spasic and Davorin Radosavljevic},
year = {2017},
journal = {OncoTargets and Therapy},
doi = {10.2147/ott.s131756},
url = {https://doi.org/10.2147/ott.s131756}
}RIS
TY - JOUR TI - Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report AU - Dragana Jovanovic AU - Ruza Stevic AU - Marta Velinovic AU - Milica Kontic AU - Dragana Maric AU - Jelena Spasic AU - Davorin Radosavljevic PY - 2017 JO - OncoTargets and Therapy DO - 10.2147/ott.s131756 UR - https://doi.org/10.2147/ott.s131756 ER -
APA
Jovanovic, D., Stevic, R., Velinovic, M., Kontic, M., Maric, D., Spasic, J., & Radosavljevic, D. (2017). Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report. OncoTargets and Therapy. https://doi.org/10.2147/ott.s131756
Source records
- crossref · retrieved 2026-09-27T02:38:57.267Z